IBDEI34B ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,49800,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49800,1,3,0)
;;=3^Heart Failure,Diastolic,Chronic
;;^UTILITY(U,$J,358.3,49800,1,4,0)
;;=4^I50.32
;;^UTILITY(U,$J,358.3,49800,2)
;;=^5007245
;;^UTILITY(U,$J,358.3,49801,0)
;;=I50.42^^193^2482^36
;;^UTILITY(U,$J,358.3,49801,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49801,1,3,0)
;;=3^Heart Failure,Systolic & Diastolic,Chronic
;;^UTILITY(U,$J,358.3,49801,1,4,0)
;;=4^I50.42
;;^UTILITY(U,$J,358.3,49801,2)
;;=^5007249
;;^UTILITY(U,$J,358.3,49802,0)
;;=I13.0^^193^2482^30
;;^UTILITY(U,$J,358.3,49802,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49802,1,3,0)
;;=3^HTN Hrt & CKD w/ Hrt Fail w/ Stage 1-4 Chr Kdny
;;^UTILITY(U,$J,358.3,49802,1,4,0)
;;=4^I13.0
;;^UTILITY(U,$J,358.3,49802,2)
;;=^5007067
;;^UTILITY(U,$J,358.3,49803,0)
;;=I13.2^^193^2482^31
;;^UTILITY(U,$J,358.3,49803,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49803,1,3,0)
;;=3^HTN Hrt & CKD w/ Hrt Fail w/ Stage 5 Chr Kdny
;;^UTILITY(U,$J,358.3,49803,1,4,0)
;;=4^I13.2
;;^UTILITY(U,$J,358.3,49803,2)
;;=^5007070
;;^UTILITY(U,$J,358.3,49804,0)
;;=I13.10^^193^2482^32
;;^UTILITY(U,$J,358.3,49804,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49804,1,3,0)
;;=3^HTN Hrt & CKD w/o Hrt Fail w/ Stage 1-4 Chr Kdny
;;^UTILITY(U,$J,358.3,49804,1,4,0)
;;=4^I13.10
;;^UTILITY(U,$J,358.3,49804,2)
;;=^5007068
;;^UTILITY(U,$J,358.3,49805,0)
;;=I13.11^^193^2482^33
;;^UTILITY(U,$J,358.3,49805,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49805,1,3,0)
;;=3^HTN Hrt & CKD w/o Hrt Fail w/ Stage 5 Chr Kdny
;;^UTILITY(U,$J,358.3,49805,1,4,0)
;;=4^I13.11
;;^UTILITY(U,$J,358.3,49805,2)
;;=^5007069
;;^UTILITY(U,$J,358.3,49806,0)
;;=E03.9^^193^2482^43
;;^UTILITY(U,$J,358.3,49806,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49806,1,3,0)
;;=3^Hypothyroidism,Unspec
;;^UTILITY(U,$J,358.3,49806,1,4,0)
;;=4^E03.9
;;^UTILITY(U,$J,358.3,49806,2)
;;=^5002476
;;^UTILITY(U,$J,358.3,49807,0)
;;=M54.5^^193^2482^46
;;^UTILITY(U,$J,358.3,49807,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49807,1,3,0)
;;=3^Low Back Pain
;;^UTILITY(U,$J,358.3,49807,1,4,0)
;;=4^M54.5
;;^UTILITY(U,$J,358.3,49807,2)
;;=^5012311
;;^UTILITY(U,$J,358.3,49808,0)
;;=C61.^^193^2482^47
;;^UTILITY(U,$J,358.3,49808,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49808,1,3,0)
;;=3^Malig Neopl Prostate
;;^UTILITY(U,$J,358.3,49808,1,4,0)
;;=4^C61.
;;^UTILITY(U,$J,358.3,49808,2)
;;=^267239
;;^UTILITY(U,$J,358.3,49809,0)
;;=F11.20^^193^2482^53
;;^UTILITY(U,$J,358.3,49809,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49809,1,3,0)
;;=3^Opioid Dependence,Uncomplicated
;;^UTILITY(U,$J,358.3,49809,1,4,0)
;;=4^F11.20
;;^UTILITY(U,$J,358.3,49809,2)
;;=^5003127
;;^UTILITY(U,$J,358.3,49810,0)
;;=M19.90^^193^2482^54
;;^UTILITY(U,$J,358.3,49810,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49810,1,3,0)
;;=3^Osteoarthritis,Unspec
;;^UTILITY(U,$J,358.3,49810,1,4,0)
;;=4^M19.90
;;^UTILITY(U,$J,358.3,49810,2)
;;=^5010853
;;^UTILITY(U,$J,358.3,49811,0)
;;=M85.80^^193^2482^55
;;^UTILITY(U,$J,358.3,49811,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49811,1,3,0)
;;=3^Osteopenia,Unspec Site
;;^UTILITY(U,$J,358.3,49811,1,4,0)
;;=4^M85.80
;;^UTILITY(U,$J,358.3,49811,2)
;;=^5014473
;;^UTILITY(U,$J,358.3,49812,0)
;;=M81.0^^193^2482^56
;;^UTILITY(U,$J,358.3,49812,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49812,1,3,0)
;;=3^Osteoporosis,Age-Related w/o Fx
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI34B 3819 printed Sep 23, 2025@20:17:33 Page 2
IBDEI34B ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,49800,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,49800,1,3,0)
+4 ;;=3^Heart Failure,Diastolic,Chronic
+5 ;;^UTILITY(U,$J,358.3,49800,1,4,0)
+6 ;;=4^I50.32
+7 ;;^UTILITY(U,$J,358.3,49800,2)
+8 ;;=^5007245
+9 ;;^UTILITY(U,$J,358.3,49801,0)
+10 ;;=I50.42^^193^2482^36
+11 ;;^UTILITY(U,$J,358.3,49801,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,49801,1,3,0)
+14 ;;=3^Heart Failure,Systolic & Diastolic,Chronic
+15 ;;^UTILITY(U,$J,358.3,49801,1,4,0)
+16 ;;=4^I50.42
+17 ;;^UTILITY(U,$J,358.3,49801,2)
+18 ;;=^5007249
+19 ;;^UTILITY(U,$J,358.3,49802,0)
+20 ;;=I13.0^^193^2482^30
+21 ;;^UTILITY(U,$J,358.3,49802,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,49802,1,3,0)
+24 ;;=3^HTN Hrt & CKD w/ Hrt Fail w/ Stage 1-4 Chr Kdny
+25 ;;^UTILITY(U,$J,358.3,49802,1,4,0)
+26 ;;=4^I13.0
+27 ;;^UTILITY(U,$J,358.3,49802,2)
+28 ;;=^5007067
+29 ;;^UTILITY(U,$J,358.3,49803,0)
+30 ;;=I13.2^^193^2482^31
+31 ;;^UTILITY(U,$J,358.3,49803,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,49803,1,3,0)
+34 ;;=3^HTN Hrt & CKD w/ Hrt Fail w/ Stage 5 Chr Kdny
+35 ;;^UTILITY(U,$J,358.3,49803,1,4,0)
+36 ;;=4^I13.2
+37 ;;^UTILITY(U,$J,358.3,49803,2)
+38 ;;=^5007070
+39 ;;^UTILITY(U,$J,358.3,49804,0)
+40 ;;=I13.10^^193^2482^32
+41 ;;^UTILITY(U,$J,358.3,49804,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,49804,1,3,0)
+44 ;;=3^HTN Hrt & CKD w/o Hrt Fail w/ Stage 1-4 Chr Kdny
+45 ;;^UTILITY(U,$J,358.3,49804,1,4,0)
+46 ;;=4^I13.10
+47 ;;^UTILITY(U,$J,358.3,49804,2)
+48 ;;=^5007068
+49 ;;^UTILITY(U,$J,358.3,49805,0)
+50 ;;=I13.11^^193^2482^33
+51 ;;^UTILITY(U,$J,358.3,49805,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,49805,1,3,0)
+54 ;;=3^HTN Hrt & CKD w/o Hrt Fail w/ Stage 5 Chr Kdny
+55 ;;^UTILITY(U,$J,358.3,49805,1,4,0)
+56 ;;=4^I13.11
+57 ;;^UTILITY(U,$J,358.3,49805,2)
+58 ;;=^5007069
+59 ;;^UTILITY(U,$J,358.3,49806,0)
+60 ;;=E03.9^^193^2482^43
+61 ;;^UTILITY(U,$J,358.3,49806,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,49806,1,3,0)
+64 ;;=3^Hypothyroidism,Unspec
+65 ;;^UTILITY(U,$J,358.3,49806,1,4,0)
+66 ;;=4^E03.9
+67 ;;^UTILITY(U,$J,358.3,49806,2)
+68 ;;=^5002476
+69 ;;^UTILITY(U,$J,358.3,49807,0)
+70 ;;=M54.5^^193^2482^46
+71 ;;^UTILITY(U,$J,358.3,49807,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,49807,1,3,0)
+74 ;;=3^Low Back Pain
+75 ;;^UTILITY(U,$J,358.3,49807,1,4,0)
+76 ;;=4^M54.5
+77 ;;^UTILITY(U,$J,358.3,49807,2)
+78 ;;=^5012311
+79 ;;^UTILITY(U,$J,358.3,49808,0)
+80 ;;=C61.^^193^2482^47
+81 ;;^UTILITY(U,$J,358.3,49808,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,49808,1,3,0)
+84 ;;=3^Malig Neopl Prostate
+85 ;;^UTILITY(U,$J,358.3,49808,1,4,0)
+86 ;;=4^C61.
+87 ;;^UTILITY(U,$J,358.3,49808,2)
+88 ;;=^267239
+89 ;;^UTILITY(U,$J,358.3,49809,0)
+90 ;;=F11.20^^193^2482^53
+91 ;;^UTILITY(U,$J,358.3,49809,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,49809,1,3,0)
+94 ;;=3^Opioid Dependence,Uncomplicated
+95 ;;^UTILITY(U,$J,358.3,49809,1,4,0)
+96 ;;=4^F11.20
+97 ;;^UTILITY(U,$J,358.3,49809,2)
+98 ;;=^5003127
+99 ;;^UTILITY(U,$J,358.3,49810,0)
+100 ;;=M19.90^^193^2482^54
+101 ;;^UTILITY(U,$J,358.3,49810,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,49810,1,3,0)
+104 ;;=3^Osteoarthritis,Unspec
+105 ;;^UTILITY(U,$J,358.3,49810,1,4,0)
+106 ;;=4^M19.90
+107 ;;^UTILITY(U,$J,358.3,49810,2)
+108 ;;=^5010853
+109 ;;^UTILITY(U,$J,358.3,49811,0)
+110 ;;=M85.80^^193^2482^55
+111 ;;^UTILITY(U,$J,358.3,49811,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,49811,1,3,0)
+114 ;;=3^Osteopenia,Unspec Site
+115 ;;^UTILITY(U,$J,358.3,49811,1,4,0)
+116 ;;=4^M85.80
+117 ;;^UTILITY(U,$J,358.3,49811,2)
+118 ;;=^5014473
+119 ;;^UTILITY(U,$J,358.3,49812,0)
+120 ;;=M81.0^^193^2482^56
+121 ;;^UTILITY(U,$J,358.3,49812,1,0)
+122 ;;=^358.31IA^4^2
+123 ;;^UTILITY(U,$J,358.3,49812,1,3,0)
+124 ;;=3^Osteoporosis,Age-Related w/o Fx
